Johnson & Johnson (JNJ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Healthcare | Drug Manufacturers (Major) | 89 | 5.7% |
| Current Price (06/25) | $144.24 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 81,424.5 | |||
| Sales Growth Forecast | 4.0% | |||
| Net Profit Margin | 28.8% | |||
| Projected Shares Outstanding | 2,531.25 | |||
| EPS - Five year Forecast | $11.29 | |||
| Average P/E Ratio | 15.0 | |||
| Projected Average Price | $169.33 | |||
| Price Appreciation (Annualized) | 3.3% | |||
| Annual Dividend Yield | 2.4% | |||
| Projected Annual Return | 5.7% | |||
| Quality | ||||
| Financial Strength | 99 | 24.7 | ||
| EPS Stability | 88 | 22.1 | ||
| Industry Sales Growth Rate | 8.0% | 6.3 | ||
| Industry Net Profit Margin | 22.5% | 16.0 | ||
| Calculated Quality Rating | 69.1 | |||
| Fool CAPS | ||||
Total Players
13611
Outperforms
512
Underperforms
All-Stars (3146)
3080
Outperforms (98%)
66
Underperforms
|
||||
| Fundamental Data Updated: 06/21/2019 | ||||